Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2026-05-22 18:59:58 ET · period of report 2026-05-15 · accession 0001832579-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 18:59 | 2026-05-15 | MRVI | ORESHACK KURT | GC | A - Grant | $2.84 | +776 | 385.8K | +0.2% | +$2,204 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-05-15 | A | A | 776 | $2.84 | 385,767 | D | — | — | (F1) The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 776 shares of Class A Common Stock was exempt pursuant to Rule 16b-3. |